Universitätsklinikum Hamburg-Eppendorf (UKE)

Pathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function (2025) Asadollahi R, Ahmad A, Boonsawat P, Shahanoor Hinzen J, Lohse M, Bouazza-Arostegui B, Sun S, et al. Journal article Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study (2025) Ferdinandus S, Rühle A, Lamrani A, Frei C, Kaufmann J, Mäurer M, Wurschi G, et al. Journal article Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients (2025) Ugurel S, Abu Rached N, Gambichler T, Mengoni M, Tüting T, Hassel JC, Reschke R, et al. Journal article Intravenous thrombolysis before percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome and acute ischaemic stroke: a subanalysis of the PRAISE study (2025) Sedghi A, Von Rennenberg R, Petzold G, Nickenig G, Kallmünzer B, Achenbach S, Huber R, et al. Journal article Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC (2025) Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Diniz MA, Asada N, Ayuk F, et al. Journal article Transmission Electron Microscopy-based characterization of Extracellular Vesicles from plasma and serum from Parkinson´s Disease patients (2025) Weiß A, Meissner A, Boros FA, Regensburger M, Taudte RV, Matamoros-Angles A, Arnold P, et al. Journal article Long QT syndrome in children and adolescents: risk factors and outcomes in a large German cohort (2025) Lippert L, Burkard T, Markel F, Debus V, Stute F, Kamphues A, Dalla Pozza R, et al. Journal article Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG (2025) Leven AS, Peters T, Rajcsanyi LS, Weichenthal M, Mohr P, Meier F, von Wasielewski I, et al. Journal article Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial (2025) Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, et al. Journal article